AQUABEAM SYSTEM 220101

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2020-03-02 for AQUABEAM SYSTEM 220101 manufactured by Procept Biorobotics Corporation.

Event Text Entries

[188340343] A review of the log file was conducted and no anomalies were observed. The review indicated that the system functioned as designed. A review of the device history record (dhr) for the aquabeam system, lot number 18c00106, was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system, which could relate to the reported event. The review indicated that the system met all required specifications when released for distribution. The aquabeam system's instructions for use (ifu), ifu320301, rev. D, was reviewed and capsular perforation is listed as a potential perioperative risk of the aquablation procedure. The system was not returned for investigation of this complaint. Capsular perforation is a potential risk of the aquablation procedure. Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.
Patient Sequence No: 1, Text Type: N, H10


[188340344] A male patient underwent an aquablation procedure. Per standard post-aquablation procedure, during clot evacuation a prostatic capsule perforation was seen by transrectal ultrasound (trus) and later confirmed by cystoscopy (per manufacturer's instructions for use, prostate capsule perforation is a potential perioperative risk of the aquablation procedure). In response to the capsular perforation, the physician decided to leave the foley balloon urinary catheter in place for four (4) days rather than the typical one (1) to two (2) days post-aquablation procedure to allow for healing of the perforation. There were no reported adverse health consequences to the patient following removal of the catheter or as result of the capsular perforation. No malfunction of the aquabeam system was reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3012977056-2020-00003
MDR Report Key9775038
Report SourceHEALTH PROFESSIONAL
Date Received2020-03-02
Date of Report2020-03-02
Date of Event2018-05-10
Date Mfgr Received2018-05-10
Device Manufacturer Date2018-02-09
Date Added to Maude2020-03-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. DORIA ESQUIVEL
Manufacturer Street900 ISLAND DRIVE SUITE 170
Manufacturer CityREDWOOD CITY, CA
Manufacturer CountryUS
Manufacturer Phone2327291
Manufacturer G1PROCEPT BIOROBOTICS CORPORATION
Manufacturer Street900 ISLAND DRIVE SUITE 101
Manufacturer CityREDWOOD CITY, CA
Manufacturer CountryUS
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAQUABEAM SYSTEM
Generic NameFLUID JET REMOVAL SYSTEM
Product CodePZP
Date Received2020-03-02
Catalog Number220101
Lot Number18C00106
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerPROCEPT BIOROBOTICS CORPORATION
Manufacturer Address900 ISLAND DRIVE SUITE 101 REDWOOD CITY, CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2020-03-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.